1)Matsui Y, Tanizaki Y, Arima H, Yonemoto K, Doi Y, et al: Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study. J Neurol Neurosurg Psychiatry 80: 366-370, 2009
2)Honda H, Sasaki K, Hamasaki H, Shijo M, Koyama S, et al: Trends in autopsy-verified dementia prevalence over 29 years of the Hisayama study. Neuropathology 36: 383-387, 2016
3)McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, et al: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89: 88-100, 2017
4)Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, et al: The consortium to establish a registry for Alzheimer's disease (CERAD): part II. standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486, 1991
5)Thal DR, Rüb U, Orantes M, Braak H: Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58: 1791-1800, 2002
6)Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239-259, 1991
7)Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, et al; National Institute on Aging; Alzheimer's Association: National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 123: 1-11, 2012
8)Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, et al: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211, 2003
9)Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, et al: Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol 141: 159-172, 2021
10)Yamada M, Itoh Y, Otomo E, Suematus N, Matsushita M: Dementia of the Alzheimer type and related dementias in the aged: DAT subgroups and senile dementia of the neurofibrillary tangle type. Neuropathology 16: 89-98, 1996
11)Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, et al: Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128: 755-766, 2014
12)Yamada M: Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis. Neuropathology 23: 311-317, 2003
13)Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, et al: Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63: 911-918, 2004
14)Tolnay M, Clavaguera F: Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. Neuropathology 24: 269-283, 2004
15)Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, et al: Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol 126: 161-177, 2013
16)Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, et al: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142: 1503-1527, 2019
17)Kalaria RN: Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease. Acta Neuropathol 131: 659-685, 2016
18)Skrobot OA, Attems J, Esiri M, Hortobágyi T, Ironside JW, et al: Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain 139: 2957-2969, 2016
19)Yamada M: Cerebral amyloid angiopathy: emerging concepts. J Stroke 17: 17-30, 2015
20)Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, et al: Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 69: 320-327, 2011
21)Sakai K, Hayashi S, Sanpei K, Yamada M, Takahashi H: Multiple cerebral infarcts with a few vasculitic lesions in the chronic stage of cerebral amyloid angiopathy-related inflammation. Neuropathology 32: 551-556, 2012
22)Takeda S, Yamazaki K, Miyakawa T, Onda K, Hinokuma K, et al: Subcortical hematoma caused by cerebral amyloid angiopathy: does the first evidence of hemorrhage occur in the subarachnoid space? Neuropathology 23: 254-261, 2003
23)Sakai K, Boche D, Carare R, Johnston D, Holmes C, et al: Aβ immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy. Acta Neuropathol 128: 777-789, 2014
24)Sakai K, Asakawa M, Takahashi R, Ishida C, Nakamura R, et al: Coexistence of transthyretin- and Aβ-type cerebral amyloid angiopathy in a patient with hereditary transthyretin V30M amyloidosis. J Neurol Sci 381: 144-146, 2017
25)Yamada M, Itoh Y, Shintaku M, Kawamura J, Jensson O, et al: Immune reactions associated with cerebral amyloid angiopathy. Stroke 27: 1155-1162, 1996
26)Salvarani C, Hunder GG, Morris JM, Brown RD Jr, Christianson T, et al: Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology 81: 1596-1603, 2013
27)Sakai K, Yamada M: Cerebral amyloid angiopathy-related inflammation and dementia. Clin Exp Neuroimmunol 12: 101-106, 2021
28)Ishida C, Sakajiri K, Yoshita M, Joutel A, Cave-Riant F, et al: CADASIL with a novel mutation in exon 7 of NOTCH3 (C388Y). Intern Med 45: 981-985, 2006
29)Gray F, Keohane CK: Spirochetal infections of the CNS. Chrétien F, Wong KT, Sharer LR (eds): Infections of the Central Nervous System: Pathology and Genetics. Wiley Blackwell, New Jersey, 2020, pp 363-377
30)Gray F, Sharer LR: Human immunodeficiency virus infection of the CNS. 前掲29), pp 215-229
31)坂井健二, 中島 孝, 福原信義: ミオクローヌスと運動失調を主症状としナイアシン投与が有効であったアルコール性ペラグラ脳症が疑われた1例. Brain Nerve 58: 141-144, 2006